Dr. Gunnveig Grødeland obtained her Ph.D. in immunology and vaccinology in 2013 from the University of Oslo in Norway. She has since worked at the University of Oslo and Oslo University Hospital, interrupted by a Fulbright Scholarship to The Scripps Research Institute in San Diego. Grødeland is presently leading her research group on Influenza and Adaptive Immunity, and is also Dep. Director of K.G. Jebsen Centre for Influenza Vaccine Research in Norway. Her research interests has focused on development of novel vaccine formats against infectious diseases, and she is presently preparing a lead vaccine candidate against pandemic influenza for clinical testing.
Speaking In
[Available On-Demand]
SPARK Norway is the innovation program at the University of Oslo, and Grødeland is one of the…